| Dabigatran versus warfarin in patients with atrial fibrillation SJ Connolly, MD Ezekowitz, S Yusuf, J Eikelboom, J Oldgren, A Parekh, ... New England journal of medicine 361 (12), 1139-1151, 2009 | 14267 | 2009 |
| Rivaroxaban versus warfarin in nonvalvular atrial fibrillation MR Patel, KW Mahaffey, J Garg, G Pan, DE Singer, W Hacke, G Breithardt, ... New England Journal of Medicine 365 (10), 883-891, 2011 | 11526 | 2011 |
| Angiotensin–neprilysin inhibition versus enalapril in heart failure JJV McMurray, M Packer, AS Desai, J Gong, MP Lefkowitz, AR Rizkala, ... New England Journal of Medicine 371 (11), 993-1004, 2014 | 6792 | 2014 |
| Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension JA Staessen, R Fagard, L Thijs, H Celis, GG Arabidze, WH Birkenhäger, ... The Lancet 350 (9080), 757-764, 1997 | 4278 | 1997 |
| Rivaroxaban in patients with a recent acute coronary syndrome JL Mega, E Braunwald, SD Wiviott, JP Bassand, DL Bhatt, C Bode, ... New England Journal of Medicine 366 (1), 9-19, 2012 | 2441 | 2012 |
| Clopidogrel with or without omeprazole in coronary artery disease DL Bhatt, BL Cryer, CF Contant, M Cohen, A Lanas, TJ Schnitzer, ... New England Journal of Medicine 363 (20), 1909-1917, 2010 | 1567 | 2010 |
| Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. S Yusuf, SR Mehta, S Chrolavicius, J Pogue, CB Granger, A Budaj, ... JAMA: Journal of the American Medical Association 295 (13), 2006 | 1178 | 2006 |
| Prasugrel versus clopidogrel for acute coronary syndromes without revascularization MT Roe, PW Armstrong, KAA Fox, HD White, D Prabhakaran, ... New England journal of medicine 367 (14), 1297-1309, 2012 | 1081 | 2012 |
| Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure M Packer, JJV McMurray, AS Desai, J Gong, MP Lefkowitz, AR Rizkala, ... Circulation 131 (1), 54-61, 2015 | 783 | 2015 |
| Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin‐converting enzyme inhibition in patients with chronic systolic heart failure: rationale for … JJV McMurray, M Packer, AS Desai, J Gong, MP Lefkowitz, AR Rizkala, ... European journal of heart failure 15 (9), 1062-1073, 2013 | 515 | 2013 |
| Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial ML O’Donoghue, E Braunwald, HD White, DL Steen, MA Lukas, E Tarka, ... Jama 312 (10), 1006-1015, 2014 | 466 | 2014 |
| Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa … JL Halperin, GJ Hankey, DM Wojdyla, JP Piccini, Y Lokhnygina, MR Patel, ... Circulation 130 (2), 138-146, 2014 | 462 | 2014 |
| Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF GJ Hankey, MR Patel, SR Stevens, RC Becker, G Breithardt, A Carolei, ... The Lancet Neurology 11 (4), 315-322, 2012 | 459 | 2012 |
| Risk related to pre–diabetes mellitus and diabetes mellitus in heart failure with reduced ejection fraction: insights from prospective comparison of ARNI With ACEI to determine … SL Kristensen, D Preiss, PS Jhund, I Squire, JS Cardoso, B Merkely, ... Circulation: Heart Failure 9 (1), e002560, 2016 | 368 | 2016 |
| Bempedoic acid and cardiovascular outcomes in statin-intolerant patients SE Nissen, AM Lincoff, D Brennan, KK Ray, D Mason, JJP Kastelein, ... New England Journal of Medicine 388 (15), 1353-1364, 2023 | 348 | 2023 |
| The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes SG Goodman, W Huang, AT Yan, A Budaj, BM Kennelly, JM Gore, ... American heart journal 158 (2), 193-201. e5, 2009 | 279 | 2009 |
| Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly JA Staessen, R Fagard, L Thijs, H Celis, WH Birkenhäger, CJ Bulpitt, ... Archives of Internal medicine 158 (15), 1681-1691, 1998 | 204 | 1998 |
| Cause of death and predictors of all‐cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: data from ROCKET AF SD Pokorney, JP Piccini, SR Stevens, MR Patel, KS Pieper, JL Halperin, ... Journal of the American Heart Association 5 (3), e002197, 2016 | 154 | 2016 |
| 36th international symposium on intensive care and emergency medicine: Brussels, Belgium. 15-18 March 2016 RM Bateman, MD Sharpe, JE Jagger, CG Ellis, J Solé-Violán, ... Critical care 20, 13-182, 2016 | 150 | 2016 |
| Terminal digit preference and single-number preference in the Syst-Eur trial: influence of quality control D Wingfield, J Cooke, L Thijs, JA Staessen, AE Fletcher, R Fagard, ... Blood pressure monitoring 7 (3), 169-177, 2002 | 77 | 2002 |
